Comparison of biometric parameters in primary glaucomas and refractive errors. by Rajalakshmi, A R
 1
 
 
A Dissertation On 
 
COMPARISON OF BIOMETRIC PARAMETERS IN PRIMARY 
GLAUCOMAS AND REFRACTIVE ERRORS. 
 
Submitted to 
THE TAMILNADU DR. M.G.R MEDICAL UNIVERSITY 
CHENNAI 
 
With fulfillment of the regulations 
 for the award of the degree of 
 
M.S (OPHTHALMOLOGY) 
 
BRANCH-III 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REGIONAL INSTITUTE OF OPHTHALMOLOGY 
GOVT.OPHTHALMIC HOSPITAL 
MADRAS MEDICAL COLLEGE 
CHENNAI 
 
 
March  2007 
 
 
 
 
 
 2
 
 
 
 
CERTIFICATE 
 
 
               This is to certify that this dissertation entitled 
“COMPARISON OF BIOMETRIC PARAMETERS IN PRIMARY 
GLAUCOMAS AND REFRACTIVE ERRORS” submitted by 
Dr.A.R.RAJALAKSHMI  appearing for Part II M.S Branch III 
(OPHTHALMOLOGY)  degree examination in February 2007 is a 
bonafide record of work done by her under my direct audience and 
supervision in partial fulfillment of regulations of the Tamil Nadu, 
Dr.M.G.R.Medical University ,CHENNAI,TAMILNADU.I forward 
this to the Tamil Nadu , Dr.M.G.R.Medical University Chennai, 
Tamil Nadu, India. 
 
 
 
 
Prof.DrV.VELAYUTHAM,M.S.,D.O
Chief, Glaucoma Clinic  
Regional Institute of Ophthalmology 
Government  Ophthalmic Hospital, 
Egmore, Chennai  - 600 008 
 Prof.DrV.VELAYUTHAM,M.S.,D.O
Director and Superintendent 
Regional Institute of Ophthalmology 
Government  Ophthalmic Hospital, 
Egmore, Chennai – 600 008 
 
 
 
 
 
Prof. Dr. KALAVATHY PONNIRAIVAN, B.Sc, M.D 
Dean, Madras Medical College & 
Government General Hospital, 
Chennai-600003. 
 3
 
 
 
 
 
DECLARATION 
 
 
 
              I, Dr. A.R. Rajalakshmi  solemnly declare that the dissertation 
titled “COMPARISON OF BIOMETRIC PARAMETERS IN 
PRIMARY GLAUCOMAS AND REFRACTIVE ERRORS”   has 
been prepared by me. This is submitted to The Tamil Nadu Dr. M.G.R. 
Medical University, Chennai, in partial fulfillment of the requirement 
for the award of  M.S.,  degree Examination to be held in March 2007. 
 
 
 
 
 
 
Place:  Chennai  
                                                                                                        
Date:                                                                  
 
 
 
 
 
 
 
 
 
 4
ACKNOWLEDGEMENT 
 
I am grateful to Prof. Dr. Kalavathy Ponniraivan, B.Sc., M.D., 
Dean, Madras Medical College , Chennai , for permitting me to utilize 
the clinical materials and allowing me to do this study. 
 
I express my profound gratitude to Prof. Dr.V. Velayutham, 
M.S., D.O., Director and Superintendent, Regional Institute of 
Ophthalmology , Government Ophthalmic Hospital , Madras Medical 
College , Chennai, for his valuable guidance .With his vast experience, 
he has guided me throughout the study and made the completion of the 
study a reality. 
 
I am extremely grateful to Prof. Dr. K. Maragadham, M.S., 
D.O for her guidance and support. 
 
I wish to thank Dr. P.S.Maheswari, M.S.,D.O, Dr. M.R.Chitra, 
M.S, Dr. N.Jayanthi, M.S.,D.O, for their help and support. 
 
I am very grateful to Dr.T.Nirmal Fredrick, M.S, who with his 
experience had rendered valuable guidance at various stages. 
 
I am thankful to all my colleagues for their valuable help 
 
I am also grateful to all my patients, without whose cooperation 
this study would not have been possible.  
 
 5
 
 
CONTENTS 
 
PART – I 
 
DEFINITION AND HISTORY      1 
 
CLASSIFICATION OF GLAUCOMA     3 
 
PRIMARY OPEN ANGLE GLAUCOMA     5 
 
PRIMARY ANGLE CLOSURE GLAUCOMA    8 
 
PATHOPHYSIOLOGY OF ANGLE CLOSURE    10 
 
BIOMETRIC PARAMETERS      12 
 
A SCAN BIOMETRY       16  
 
PACHYMETER        24 
 
PART – II 
 
AIM OF STUDY        27 
 
MATERIALS AND METHODS      28 
 
RESULTS         32 
 
DISCUSSION        47 
 
CONCLUSION        51 
 
PART – III 
 
BIBLIOGRAPHY 
PROFORMA 
MASTER CHART 
KEY TO MASTER CHART 
 6
COMPARISON OF BIOMETRIC PARAMETERS IN PRIMARY 
GLAUCOMAS AND REFRACTIVE ERRORS. 
DEFINITION: 
 “Glaucoma is a symptom complex wherein there is optic nerve head 
neuropathy with characteristic morphological and functional changes of the 
optic nerve, the major risk factor being increased intraocular pressure.” 
HISTORICAL BACKGROUND 
Although our modern understanding of glaucoma dates back to the mid 
19-th century, this group of disorders was apparently recognized by the 
Greeks as early as 400 BC. In Hippocratic writings, it appears as 
GLAUCOSIS in reference to the bluish green hue of the affected eye(1). This 
term, however was applied to a large group of blinding conditions that include 
cataracts. Although an association with elevated intraocular pressure is found 
in 10th century Arabian writings, it was not until the 19th century that 
glaucoma was clearly recognized as a distinct group of ocular disorders. 
Von Graefe reported the association of glaucoma with a shallow 
anterior chamber (2).  
Rosengren found that patients with glaucoma had a smaller anterior 
chamber depth than normal persons. He also suggested that a shallow anterior 
chamber in acute glaucoma existed prior to acute rise in pressure(3). 
Tornquist found the anterior chamber to be genetically determined(4). 
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SIGNIFICANCE OF GLAUCOMA 
Glaucoma is a leading cause of irreversible blindness throughout the 
world. The World Health Organisation statistics published in 1995, indicate 
that Glaucoma accounts for blindness in 5.1 million persons or 13.5% of 
global blindness (behind cataracts and trachoma at 15.8 million and 5.9 
million persons or 41.8 % and 15.5 % of global blindness, respectively) 
Although Glaucoma most commonly affects the elderly, it occurs in all 
segments of the society with significant health and economic consequences 
making it a major public health problem(5). Quigley has estimated that 66.8 
million people are affected by primary Glaucoma worldwide, with 6.7 million 
people being bilaterally blind due to the disease(6).     
EPIDEMIOLOGY AND MAGNITUDE 
The prevalence of primary open angle Glaucoma versus Primary angle 
closure glaucoma varies with race and religion. India has a higher prevalence 
of Primary angle closure glaucoma compared with the Western  
population (6). 
PRIMARY ANGLE CLOSURE GLAUCOMA: 
The Andhra Pradesh Eye study(7) had determined the prevalence of 
manifest PACG ( IOP 22 mm Hg , Optic disc damage and visual field loss 
with narrow angles or gonioscopy ) to be 1.08 % in individuals aged over 
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40.Occludable angles ( defined as pigmented trabecular meshwork not visible 
by gonioscopy in three quarters or more of the angles ) was prevalent in 2.21 
% in people aged over 40.With a conservative estimate of PACG to be around 
0.7 % -1.08 % in adults aged over 40 years about 3 million adult Indians have 
manifest angle closure glaucoma and another 6 million have occludable 
angles and are at risk of angle closure . Hence efficient screening measures 
are mandatory to diagnose PACG early. 
PRIMARY OPEN ANGLE GLAUCOMA: 
The Andhra Pradesh Eye study(7) had identified the prevalence of 
POAG to be 1.62 % in those aged over 30 years. The prevalence of POAG 
increased significantly with age and only 7.4 % of those diagnosed with 
glaucoma were previously diagnosed and treated. The incidence of glaucoma 
among the Ocular hypertensives is 1.5 % every year. Since increasing age is a 
significant risk factor, individuals with the burden of glaucoma would 
considerably increase in the coming decades due to increase in the life 
expectancy and the proportion of the geriatric population. 
CLASSIFICATION OF GLAUCOMAS: 
There are several systems by which the glaucomas can be classified(8). 
The two most commonly used are based on 
1) Etiology - the underlying disorder that leads to an alteration in the 
Aqueous humor dynamics. 
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2) Mechanism - the specific alteration in the anterior chamber angle that 
leads to a rise in the intraocular pressure. 
1.  CLASSIFICATION BASED ON ETIOLOGY: 
 The Glaucomas have traditionally been divided on the basis of 
primary and secondary forms. 
a) PRIMARY: Confined to the anterior chamber angle or 
conventional outflow pathway, with no apparent contribution from other 
ocular or systemic disorders. 
b) SECONDARY: Partial understanding of the underlying 
predisposing ocular or systemic events. 
2.  CLASSIFICATION BASED ON MECHANISM: 
a) OPEN ANGLE GLAUCOMA: Those in which the anterior 
chamber angle structures i.e. the trabecular meshwork, ciliary body band are 
visible by gonioscopy. The elements obstructing the aqueous outflow may be 
located on the anterior chamber side of the trabecular meshwork (pre 
trabecular), within the trabeculum or distal to the meshwork in the Schlemm’s 
canal or further along the aqueous drainage system (post trabecular 
mechanism)   
 
 10
b) ANGLE CLOSURE GLAUCOMA: This includes situations in 
which the peripheral iris is in apposition with the trabecular meshwork or the 
peripheral cornea. The peripheral iris may either be pulled (anterior 
mechanism) or pushed (posterior mechanism) into this position. 
c) Developmental anomalies of the anterior chamber angle. 
PRIMARY OPEN ANGLE GLAUCOMA   : 
POAG is a multi factorial syndrome in which acquired progressive 
optic nerve damage is related at least in part to intraocular pressure higher 
than the nerve fibres can tolerate. The different types of glaucomas are 
calculated to be responsible for 15 % of the world’s blindness, placing 
glaucoma as the third leading cause of blindness worldwide(9). 
RISK FACTORS:  
 INTRAOCULAR PRESSURE   
The prevalence of POAG increases with increasing intraocular 
pressure. The risk of glaucoma is greater with progressively higher levels of 
baseline intraocular pressure. Elevated intraocular pressure is a treatable 
major cause of development of glaucomatous optic nerve damage; lowering 
the intraocular pressure may halt or at least inhibit the worsening of 
glaucomatous optic neuropathy in many patients. 
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AGE 
The prevalence of POAG increases with age. Older people may have 
greater susceptibility to optic nerve damage than younger people at the same 
level of IOP. 
 RACE 
The prevalence of POAG is four to five folds greater in blacks than in 
other races. Blindness from glaucoma is four to eight times more common in 
blacks than in whites. 
FAMILY HISTORY 
Family history is a risk factor for glaucoma. The relative risk of having 
POAG is increased approximately 3.7-fold for individuals who have a sibling 
with POAG. In the Rotterdam Eye Study, the prevalence was 10.4% in 
siblings of patients. The same authors estimated that the relative risk of 
having POAG was 9.2-fold for individuals who have a relative with POAG, 
and they calculated that the attributable proportion of genetic factors to the 
overall occurrence of glaucoma in the general population was 16.4%. 
MYOPIA 
The association between myopia and glaucoma is complex. Glaucoma 
patients have a higher prevalence of myopia compared with the general 
population. Myopes also have a greater incidence of glaucoma than non 
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myopes. A relationship between myopia and increased IOP may suggest that 
the pressure is the factor influencing the fact that a higher percentage of 
myopes are affected by glaucoma. One study reported a higher incidence of 
myopia in POAG patients with normal Intra Ocular Pressure, postulating that 
a structural problem in the optic nerve or the peripapillary tissue layers in 
myopia may contribute in some way to vulnerability to pressure even in the 
normal range 
 DIABETES MELLITUS 
Because Diabetes can compromise the microcirculation of various 
organs, including the optic nerve, in theory Diabetes could predispose the 
optic nerve to damage. 
OTHER FACTORS 
There appears to be a subset of patients with low diastolic perfusion 
pressures (diastolic blood pressure minus IOP) who are at higher risk for 
POAG. In studies where the presence of diabetes mellitus is confirmed by 
physiological indicators, there appears to be an association with POAG. In 
studies where diabetes mellitus presence is self-reported, there is no 
detectable association. The association between factors such as concurrent 
cardiovascular disease, systemic hypertension, and myopia, and POAG has 
not been demonstrated consistently. Migraine headache and peripheral 
vasospasm are additional possible risk factors for glaucomatous optic nerve 
damage. 
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In addition to the knowledge gained from epidemiological studies and 
clinical trials about POAG, there are two clinically useful empirical 
observations: 
Past damage predicts future damage, unless the IOP is lowered. 
Damage in one eye is associated with a significantly increased risk of future 
damage in the other eye (29% of untreated, undamaged fellow eyes will 
develop field loss in an average of 5 years). 
PRIMARY ANGLE CLOSURE GLAUCOMA 
Primary angle closure glaucoma is appositional or synechial closure of 
the anterior chamber angle caused by papillary block in the absence of other 
causes of angle closure(9).  
RISK FACTORS 
Primary angle closure glaucoma is less common than primary open 
angle glaucoma in most population based studies. Typical acute angle closure 
is most common in hyperopic women in the late middle age. Although acute 
angle closure is the most notable event, the various forms of chronic angle 
closure are far more common. 
RACE 
Epidemiological data show that in contrast to the predominance of 
open angle glaucoma among the western populations forms of angle closure 
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glaucoma predominate among Alaskans Greenland Eskimos Asians and 
Chinese, Taiwanese and Vietnamese. Angle closure glaucoma is less common 
among blacks who tend to have the chronic form of the disease.  
AGE 
Prevalence of Primary angle closure glaucoma increases with age. This 
finding could be related to the decrease in depth and volume of the anterior 
chamber which may result from progressive thickening and forward 
displacement of the lens.  
SEX 
Acute angle closure develops in women at a rate three to four times 
more than in men. This higher rate is thought to be due to a significantly 
shallower anterior chamber in women than in men.  
REFRACTION 
Hypermetropia is typically found in patients with Primary angle 
closure glaucoma. The hypermetropic eye tends to have smaller dimensions 
than the emetropic or myopic eye. 
FAMILY HISTORY 
 The risk of angle closure for first degree relatives is 2% to 5%. 
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PATHOPHYSIOLOGY OF ANGLE CLOSURE 
Eyes predisposed to angle closure glaucoma have certain anatomical 
characteristics: 
-  A shallow anterior chamber 
-  Narrow chamber angles 
-  A thick lens with a more anterior lens position 
-  An increased ratio of lens thickness to axial length of the group 
Angle closure attacks are typical in the elderly, patients who are 
hyperopic or nanophthalmic and women rather than men because they have 
shallow anterior chambers and narrow angles. Lens - Iris apposition partially 
impedes aqueous flow from the posterior to the anterior chamber (relative 
pupillary Block). This results in a pressure gradient between the posterior and 
anterior chambers, which leads to anterior bowing of the peripheral iris. In 
eyes with shallow anterior chamber angles or narrow anterior chamber angles 
or with extreme degrees of pupillary block, the anterior bowing may push the 
iris against the trabecular mesh work. This appositional angle closure may be 
sufficiently tight to block aqueous outflow, precipitating a rise in intraocular 
pressure or a frank acute attack. If the attack is not relieved, a permanent 
closure of the angle results from the formation of peripheral anterior 
synechiae.  
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RELATIVE PUPILLARY BLOCK 
The most common mechanism leading to angle closure glaucoma 
appears to be an increased resistance to aqueous flow from the posterior to the 
anterior chamber between the iris and the lens. An eye with a shallow 
chamber has a wider zone of contact between the surfaces of the iris and lens. 
This increases the pressure in the posterior chamber, causing the thin 
peripheral iris to bulge into the anterior chamber angle.  
ANATOMIC FACTORS PREDISPOSING TO PUPILLARY BLOCK 
Several anatomical aspects of the eye combine to produce a shallow 
anterior chamber. These include 
-  A thicker, more anteriorly placed lens. 
-  A small diameter, shorter posterior curvature of the cornea 
-  A shorter axial length of the globe. 
-  The lens thickness / axial length ratio appears to correlate best 
with the predisposition to angle closure. It has also been shown that the 
anterior chamber depth is not a static dimension but can undergo a rapid 
transient change. 
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SIGNIFICANCE OF PUPILLARY DILATATION 
In mid dilatation, (5 - 6 mm pupil diameter) relative pupillary block 
increases, resulting in a further rise in pressure in the posterior chamber with 
movement of the peripheral iris anteriorly in to the angle. Marked dilatation 
can cause angle closure by jamming the iris into the angle. 
BIOMETRIC PARAMETERS 
Clinic based studies have suggested that eyes with occludable angles 
and angle closure glaucoma have a shorter axial length, shallower anterior 
chamber and a thicker lens (10 – 14). The shallower anterior chambers are in 
part because of the thicker and more anterior position of the crystalline lens 
(10). Progressive increase in lens thickness with age results in greater 
shallowing of the anterior chamber(8). 
ANTERIOR CHAMBER DEPTH 
The anterior chamber is bound anteriorly by the inner surface of the 
cornea and posteriorly by the lens centrally, anterior surface of the iris and 
anterior face of the ciliary muscle peripherally (15). It communicates with the 
extra cellular space of the iris, ciliary body, trabecular mesh work and with 
the posterior chamber of the eye through the pupillary aperture. The volume 
of anterior chamber is approximately 220 microlitres and the average depth is 
3.15 mm. the chamber depth decreases by 0.01mm per year of life and is 
shallower in the hypermetropic than the myopic eye. The diameter of the 
anterior chamber varies between 11.3 and 12.4 mm. 
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LENS THICKNESS 
The lens of the eye is a transparent, biconvex, elliptical, semisolid, 
avascular body of crystalline appearance located between the iris and the 
vitreous. The equatorial diameter of the adult lens is 9 - 10 mm. By direct 
measurement, its axial sagittal width is about 3.5 - 4 mm at birth, about 4 mm 
at 40 years and increases slowly to 4.5 to 5 mm in extremes of age. In 
contrast, its equatorial diameter is 6.5 mm at birth, 9 - 10mm in the second 
decade and changes little thereafter.  
AXIAL LENGTH 
The eyeball is made up of two spheres of different sizes placed one in 
front of the other. The anterior smaller segment is transparent and forms about 
one sixth of the eyeball. It has a radius of curvature of about 8mm. the 
posterior larger segment is opaque and forms about five sixth of the eyeball. It 
has a radius of about 12mm. The antero-posterior diameter of the eye 
measures about 24mm. Since the eyeball is slightly flattened in a vertical 
plane, the vertical diameter is about 23mm; the horizontal diameter is about 
23 mm,  
The larger the antero-posterior diameter of the eye, the more myopic 
the eye is. Conversely, the shorter the antero-posterior diameter of the eye, the 
more likely it is that the eye will be hypermetropic. 
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CENTRAL CORNEAL THICKNESS 
The normal cornea has a central thickness of about 0.52 mm and 
becomes thicker in the paracentral zone (from about 0.52mm inferiorly to 
0.57mm superiorly) and peripheral zone (from 0.63mm inferiorly to 0.67mm 
superiorly). The thinnest zone is about 1.5mm temporal to the geographic 
centre. The corneal thickness is a sensitive indicator of endothelial physiology 
that correlates well with the functional measurements such as aqueous flouro-
photometry. 
Central corneal thickness (CCT) is a risk factor in that it affects 
accuracy of IOP measurements by all applanation techniques. Corneal 
thickness above 555 mm produces falsely high IOP readings; corneal 
thickness less than 540 mm produces falsely low IOP readings. The more the 
thickness deviates from the range 540 mm to 555 mm, the greater the effect. 
A thin central cornea (for example, 490 mm) may explain loss of visual field 
in an eye despite normal applanation IOP measurements because the 
measurements do not reflect a higher true IOP.  
Conversely, a thick central cornea (for example 610 mm) may explain 
worrisomely high measured IOP associated with longstanding normal visual 
field and optic disc, due to a lower true IOP. 
Ehlers et al extrapolated that applanation tonometry is overestimated or 
underestimated by approximately 5 mm Hg for every 70 mm difference in 
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measured CCT from the normal thickness of about 545 mm. Identification of 
a thin central corneal thickness may support a decision to treat eyes with a 
normal IOP measurement result. Monitoring without treatment may be 
justified in eyes with an elevated IOP measurement result and a thick cornea. 
It is possible that central corneal thickness may itself constitute an intrinsic 
risk (or protective) factor for glaucomatous optic nerve damage.   
DETERMINATION OF CENTRAL CORNEAL THICKNESS 
Central corneal thickness is determined in each eye, preferably with an 
Ultrasound-based electronic pachymeter. Evaluation of corneal thickness aids 
interpretation of IOP measurement results. Corneal thickness above 555 mm 
produces falsely high IOP readings, and corneal thickness less than 540 mm 
produces falsely low IOP readings. The more the thickness deviates from the 
range of 540 to 555 mm, the greater the effect. 
LENS THICKNESS / AXIAL LENGTH FACTOR 
In normal eyes and in those with angle closure glaucoma, shallowing 
of the angle occurs as a dynamic life long process mainly secondary to lens 
growth. This dynamic situation could actually translate into a direct 
relationship between the lens volume change and the eyeball volume. This 
can be further defined as a ratio of lens thickness to axial length. If the lens 
thickness increases or the eyeball axial length shortens, the angle will become 
shallower because of forward iris displacement. The lens thickness to axial 
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length ratio multiplied by 10 provides an index with values of one or more, 
which we refer to as the lens thickness / axial length factor (LAF) (16). This 
factor standardises the assessment of eyes with angle closure of glaucoma. It 
is highly reliable and reproducible and could easily chart the clinical course of 
the eye examined.  
A-SCAN BIOMETRY 
Axial length measurement of the eye has become one of the most 
important functions of ophthalmic ultrasound. The most common use of 
echography in the eye is the measurement of axial eye length for intraocular 
lens calculations. In addition, the measurement of axial eye length is useful in 
differentiating and monitoring certain ocular conditions (17). 
PHYSICAL PROPERTIES 
Ultrasound is an acoustic wave which consists of an oscillation of 
particles within a medium. By definition, Ultrasound waves have frequencies 
greater than 20 KHz which is inaudible to humans. Frequencies used in 
ophthalmic ultrasound range from 8 – 10 MHz. Very high frequencies 
produce short wave length (less than 0.2 mm) which allows good resolution 
of minute ocular structures.  
Ultrasound is propagated as a longitudinal wave that consists of 
alternating compressions and rarefactions of molecules as the wave passes 
through the medium. Velocity of the ultrasound depends upon the media e.g. 
Water, which is compressible, transmits the sound waves at a lower velocity 
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than do more solid media which are less compressible. As a result sound 
waves travel faster through a solid lens than it does through a liquid vitreous. 
MEDIUM VELOCITY (m/sec) 
Water 1480 
Aqueous/Vitreous 1532 
Soft tissue 1550 
Crystalline lens 1641 
 
Ultrasound waves behave like light rays. When longitudinal waves 
travel through a tissue, a part of the wave may be reflected back towards the 
source of emitted energy. This reflected wave is referred to as an echo. 
ECHOES 
Echoes are produces by acoustic interfaces that are created at the 
junction of two media that have different acoustic impedances. The acoustic 
impedance of a medium is determined by its sound velocity and its density. 
Greater the difference in acoustic impedance of two media that produce the 
interface, stronger is the reflection of the ultrasound wave. 
Returning echoes are affected by many factors which include 
a) Angle of incidence 
b) Size, shape, smoothness of acoustic interfaces 
c) Absorption 
d) Scattering 
e) Refraction 
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PULSE ECHO SYSTEM 
Pulse echo requires the production of multiple short pulses of 
ultrasound energy with a brief interval between the pulses that allows for 
returning echoes to be detected, processed and displayed. 
Basis of pulse echo system is the piezo-electric element, quartz or 
ceramic crystal, which is the key component of the ultrasound transducer. The 
piezo-electric crystal located near the face of the probe undergoes a 
mechanical vibration when stimulated by electrical energy (i.e. Voltage pulse) 
from the instrument. The vibration causes a longitudinal ultrasound wave to 
be propagated through the medium. A pause of several micro seconds then 
occurs which allows the transducer time to receive the returning echoes. The 
returning energy creates another mechanical vibration as it strikes the crystal. 
This vibration produces an electrical signal that is transmitted to the receiver 
and the display screen. This process of emitting a sound wave alternating with 
receiving an echo is repeated thousands of times per second to produce a “real 
time” display.  
COMPONENTS OF A-SCAN 
A-Scan has three components namely 
a) Probe / Transducer 
b) Receiver 
c) Oscilloscope Display 
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PROBE / TRANSDUCER 
First generation of contact biometers used water filled probes with a 
soft membranous tip. Current biometers use a solid probe that requires less 
maintenance and avoids many of the problems inherent in water filled probes. 
Solid tip probe can more easily indent the cornea, resulting in shortened axial 
length reading. Nevertheless, in most cases the experiences examiner can 
learn to apply the probe with minimal pressure, there by preventing corneal 
compression. 
Another important component of ultrasound probe is the damping 
material which is attached to the back of the crystal. It limits the vibration of 
the crystal that produces the pulses of ultrasonic energy, thus shortening the 
pulse and increases the resolution of the ultrasound system. Axial resolution is 
the minimum distance between two interfaces (echo sources) along the 
direction of the sound beam that can be displayed. Shorter the pulse, better the 
axial resolution. 
RECEIVER 
Following transducer excitation, echoes from the ocular and orbital 
interfaces impinge upon the transducer. The voltage pulses generated in 
response to these ultrasonic echoes must be modified which includes 
amplification, compensation, compression, demodulation and rejection before 
they can be displayed in a useful format. The required modifications are 
carried out by an electronic receiver.  
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A receiver can also incorporate additional processing techniques such 
as time-varied gain to compensate for tissue absorption. Another common 
feature employed in receiver is the electronic rejection of signals under a 
certain threshold level so that noise and small extraneous signals are not 
displayed.  
OSCILLOSCOPE DISPLAY 
After being processed by the receiver, echo voltages are displayed on 
an oscilloscope. Oscilloscope contains a display tube with a phosphorescent 
screen which glows when struck by an electron beam emitted from a gun at 
the base of the tube. Horizontal and vertical movement of the electron beam is 
controlled by voltages applied to deflection plates. Horizontal deflection 
plates are supplied with a voltage and vertical with processed video signals. 
These simultaneous operations sweep the electron beam over the oscilloscope 
screen yielding the desired graphic display.  
TECHNIQUES IN AXIAL LENGTH MEASUREMENTS 
Accuracy of axial length measurement is within 0.1 mm. Two 
techniques of measuring axial length with A-Scan ultrasound are  
a) Contact Technique 
b) Immersion Technique. 
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In both the techniques, the sound beam is directed along the optical 
axis of the eye. Majority of biometric A Scan instruments are digitalized 
which allows individual echograms to be stored. Most of the machines have a 
foot pedal that is depressed to freeze a given scan.  
Some biometers can be used with either contact or immersion 
techniques where as others are designed for use with only the contact method. 
Documentation of measurement can be accomplished with a photograph of 
echogram. Many of these biometers are programmed with several different 
formulae to facilitate calculation of intra ocular power. 
1.  CONTACT TECHNIQUE 
In contact technique probe is placed directly on cornea and sound beam 
is directed along the optical axis. This can be performed by holding the probe 
with the hand or by applanation. With hand held technique, the patient is 
normally seated in an upright position.  
In applanation method, probe is mounted in a pressure sensitive, spring 
loaded sleeve on a slit lamp or a similar apparatus. Patients head is positioned 
in the chin rest and the joystick is slowly advanced until the probe touches the 
center of the cornea. As soon as the measurement is obtained, the probe is 
removed and patient is encouraged to blink. Three to five high quality 
consistent measurements (within 0.3 mm) are taken.  
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SOURCES OF ERROR WITH CONTACT METHOD 
One millimeter error in axial length can result in 2.5 to 3.0 diopter 
error in post operative refraction. Primary sources of error include corneal 
compression, fluid meniscus between probe and cornea, misalignment of 
sound beam. Corneal compression results in shortened axial length 
measurement. Fluid meniscus trapped between tip of the probe and the 
cornea, may result in falsely long reading. In some cases, misalignment of 
sound beam can occur with contact method resulting in a significant error.  
2.  IMMERSION TECHNIQUE 
This method employs a smaller water bath so that the probe is not 
placed directly on the cornea. This allows display of separate corneal spike 
that is not seen with contact method. Patient is typically reclined. After topical 
anesthetic drops, a small plastic cylinder (scleral shell) is inserted between the 
lids and is filled about 2/3rd full of methyl cellulose. Patient fixates on a target 
in primary gaze and probe is immersed into the fluid. 
Beginning at a high gain setting, steeply rising, high reflective spikes 
are displayed from the interfaces namely cornea, anterior and posterior lens 
surface and retina. As the gain is turned upside down, displayed spikes 
decrease in height and ensure that all spikes remain as high and distinct as 
possible. 3 high quality echograms ranging within 0.3mm should be obtained.  
 
 28
ADVANTAGES AND DISADVANTAGES OF IMMERSION 
TECHNIQUE 
1. Examiner should be cautious when using immersion technique 
in eyes with recent intra ocular surgery or penetrating trauma. 
2. Primary advantage of immersion technique over contact method 
is that corneal compression does not occur during the examination. This is of 
particular importance in patients with short axial lengths where small errors in 
measurement can lead to significant error in post operative refraction.  
3. Problem of fluid meniscus occurring between probe tip and 
cornea is avoided with this technique. Display of separate cornea spike makes 
it easier to determine when the sound beam is properly aligned along the 
optical axis. 
DIAGNOSTIC USES OF AXIAL LENGTH MEASUREMENT 
a) Helpful in diagnosis and monitoring of certain conditions, e.g. 
microphthalmos, nanophthalmos, axial myopia, congenital glaucoma, phthisis 
bulbi. 
b) Calculation of IOL power. 
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PACHYMETER 
Pachymeter is the instrument used to measure the corneal thickness. 
Ultrasonic Pachymeter uses 20 MHz ultrasound for the measurement of 
corneal thickness. Higher frequency is ideal for differentiating corneal 
boundaries from other ocular structures because of better resolution. A 
corneal pachymeter can be optical or ultrasonic. Optical pachymetry can be 
performed using a device that attaches to the slit lamp biomicroscope, but it is 
somewhat imprecise. Ultrasonic pachymetry is both easier and more accurate. 
Instrumentation is based on the speed of the sound in the normal cornea. 
Improved signal processing and other methods such as laser interferometry 
allow the examiner to map the corneal thickness very precisely(18). 
PRINCIPLE 
The operating principle is based on timing the reflection of sound from 
the structures of interest. For corneal pachymetry, the time taken for sound to 
travel from the measuring probe in contact with the cornea to the anterior 
chamber interface and back is of interest. The direction of the ultrasonic beam 
is aligned with the visual axis.  
The ultrasound pachymeter probe tip is placed on the surface of the 
cornea. Ultrasound waves are emitted and detected by the probe. The 
computation of the corneal thickness is based on the speed with which the 
sound travels through the cornea. The thickness is measured by the time 
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interval between the anterior and posterior corneal surfaces. This 
measurement is calibrated based on the speed of sound in cornea and 
converted into micro meters.  
COMPONENTS OF ULTRASOUND PACHYMETER 
There are three major components of any ultrasound pachymeter 
a) The probe handle with its transducer and tip 
b) The housing of the instrument 
c) Accessories and convenience features 
PROBE HANDLE 
The ultrasound mechanism is contained in the pachymeter probe 
handle. All probes are hand held, smaller and lighter, easier to use clinically. 
Angled probe handles allow better visualization of the tip so as to ensure 
perpendicular application on the corneal surface.  
TRANSDUCER 
The transducer sends the beam of ultrasound waves through the probe 
tip into the cornea and receives them in return. A wide probe tip and a wide 
transducer beam reduce the accuracy of the corneal thickness reading at a 
single point.  
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PROBE TIP 
The probe tip is the interface between cornea and the transducer. The 
transducer focuses the beam at a point beyond the probe tip. The internal 
steepness of the walls, the probe diameter and its configuration all contribute 
to the internal reflection of the beam and its ultimate focusing point. 
Therefore the material in the probe tip should not attenuate the ultrasound 
beam. The diameter of the tip should be 2mm or less to diminish the area over 
which the ultrasound beam is spread and to allow the observer to see exactly 
where the tip is placed in the cornea. The surface of the tip should be smooth 
so that the corneal surface is not damaged.  
The tip is required to be held within 10 degree from the normal of the 
cornea before a reading is given. The reading is based on an averaged series 
of values computed by the instrument. The readings are accurate up to 5-10 µ. 
The most frequent number is measured as the corneal thickness. 
USES OF CORNEAL PACHYMETRY 
Corneal pachymetry can aid in the diagnosis of corneal thinning 
disorders and can also be used to assess the function of the corneal 
endothelium. A higher central corneal thickness greater than 0.65 mm 
suggests a higher risk for symptomatic corneal edema after intra ocular 
surgery. Corneal thickness can also affect the measurement of intraocular 
pressure with goldmann applanation tonometry.  
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AIM  OF THE STUDY 
• To compare the ocular biometric values in primary open angle 
glaucomas with myopic and hypermetropic refractive errors.  
 
• To analyse statistically the strength of association and 
predictability of the biometric parameters for the occurrence of 
primary angle closure glaucoma.  
 
PURPOSE OF THE STUDY 
Angle closure glaucoma is commoner in India than in the west, the 
reasons for which are not clearly understood. There is evidence in the 
literature that the eyes with angle closure glaucoma have a definite 
recognisable anatomical predisposition.  
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MATERIALS AND METHODS 
This is a prospective study done in Glaucoma Clinic - Regional 
Institute of Ophthalmology and Government Ophthalmic Hospital, Chennai 
between February 2005 and May 2006. A total of hundred patients were 
randomly selected. Informed consent was obtained from all the patients. The 
patients were divided into two groups of fifty each namely group A and  
group B.  
GROUP A - PRIMARY GLAUCOMA GROUP 
A total of fifty patients were randomly selected from those who 
attended the glaucoma clinic during the study period. 25 of them were 
primary open angle glaucoma with increased intra ocular pressure on one or 
more occasions and optic nerve head and / or visual field changes, open 
angles on gonioscopy by shaffers grading. The remaining twenty five patients 
were primary angle closure glaucoma with history of pain with or without 
redness, diminision of vision, colored haloes, increased intraocular pressure 
gonioscopically narrow angle of anterior chamber without any evidence of 
secondary cause of raised intraocular pressure. 
GROUP B - REFRACTIVE ERROR GROUP 
All the patients of this group were also randomly selected from those 
listed for refraction in the out patient department during the study period. 
Twenty five patients were with myopic refractive status and the remaining 
with hypermetropic errors.  
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SELECTION CRITERIA FOR GROUP A 
INCLUSION CRITERIA 
1. Proven cases of primary open angle and angle closure glaucoma 
only on medical treatment.  
2. Age group between 31 and 50 
3. Uncorrected visual acuity 6/12 or better.  
EXCLUSION CRITERIA 
1. Cases of primary open angle and angle closure glaucoma with 
previous surgical or laser treatment for glaucoma. 
2. Other secondary causes of glaucomas 
3. NTG / Glaucoma Suspects / OHT 
4. Congenital glaucomas 
5. Other ocular / systemic diseases 
6. Patients with significant lens changes and refractive errors 
SELECTION CRITERIA FOR GROUP B 
INCLUSION CRITERIA 
1. Age group between 11 - 30 years 
2. Refractive Error 
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 Spherical +/- 6 
 Cylindrical +/- 4 
EXCLUSION CRITERIA 
1. High refractive errors  
2. Ocular anomalies 
3. History of trauma or intra ocular surgeries 
4. History of medical or systemic illness 
5. Strabismus / Keratoconus 
All subjects underwent a complete ocular examination including visual 
acuity measurement Refraction, Slit lamp examination, Goldmann 
applanation tonometry, Gonioscopy with Goldmann single mirror. Direct and 
indirect ophthalmoscope examination, stereo biomicroscopic examination of 
the optic disc using +90D lens. Gonioscopy was performed with Goldmann's 
Single mirror in dim illumination using a shortened slit beam that did not fall 
upon the pupil. The Shaffer grading system was used for grading the patients.  
Biometric measurements were taken using the contact ultrasonography 
method with the Biomedix echorule 2 A-Scan Biometer. A drop of local 
anesthetic is instilled with the patient in semi reclined position. The patient is 
instructed to gaze steadily with the eyelids wide open. The handheld probe is 
then placed perpendicularly on the cornea.  
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The horizontal dimension of the display screen is proportional to time 
and calibrated to distance measurement. The vertical deflections from this line 
depict the position of an echo while the height of the vertical deflection is 
proportional to echo intensity. A built in tissue recognition pattern unit allows 
measurement and instant display of axial length, lens thickness and anterior 
chamber depth. Central corneal thickness of all the patients was measured 
with the Sonomed Micropach model 200P ultrasonic pachymeter.  
The patient is made to sit inclined and asked to fix a point in distance 
along the central position of gaze. The readings are taken covering the central 
cornea by placing the probe over the centre of the pupil. The probe is 
handheld and placed to ensure perpendicular corneal contact. Care is taken to 
avoid excessive corneal compression.  
Three consecutive measurement of each feature was recorded. Al the 
measurements were taken by a single trained person to avoid inter - observer 
variability. The measurements were taken for both the eyes and the mean of 
the three recording were used as the final value for both the A-Scan biometry 
and ultrasonic pachymetry.  
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RESULTS 
GROUP – A 
PRIMARY OPEN ANGLE GLAUCOMA 
AGE AND SEX DISTRIBUTION 
The number of males in POAG was 15 and the number of females was 
10. 15 of the total 25 patients were within 41-50 yrs age group and the 
remaining 10 in 31-40 yrs age group 
SEX DISTRIBUTION 
MALE 15 
FEMALE 10 
 
AGE DISTRIBUTION 
AGE IN YEARS NO: OF EYES
31 – 40 10 
41 – 50 15 
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CENTRAL CORNEAL THICKNESS 
The average CCT was 548.36 ± 24.75µ in this group of 50 eyes, out of 
which 36 eyes showed a value ranging from 501-550µ. 12 eyes had central 
corneal thickness between 551-600µ and only two eyes measured more than 
600µ. 
THICKNESS IN MICRONS NO: OF EYES
<501 Nil 
501 – 550 36 
551 – 600 12 
>600 2 
 
ANTERIOR CHAMBER DEPTH 
The ACD ranged from 3.00 – 3.50 mm in 12 eyes, 3.26 – 3.50 mm in 
28 eyes, 3.51 – 3.75 mm in 7 eyes and more than 3.76 mm in 3 eyes. The 
average ACD was 3.39 mm ± 0.20. 
DEPTH IN MM NO: OF EYES
3.00 – 3.25 12 
3.26 – 3.50 28 
3.51 – 3.75 7 
3.76 – 4.0 3 
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LENS THICKNESS 
The LT of this group showed an average value of 3.79 ± 0.19 mm, 22 
eyes measured within 3.51 – 3.75 mm followed by 21 eyes within 3.76-4.00 
mm and the rest 7 eyes measured > 4.00 mm. 
THICKNESS IN MM NO: OF EYES
< 3.50 Nil 
3.51 – 3.75 22 
3.76 – 4.00 21 
> 4.00 7 
 
AXIAL LENGTH 
The mean AL of this group of 50 eyes was 23.12 ± 0.35 mm, 26 eyes 
had an AL greater than 23.00 mm. Out of the remaining 24 eyes, 20 eyes 
showed AL to be within 22.76-23.00 mm and 4 eyes  within 22.50 – 22.75 
mm. 
LENGTH IN MM NO: OF EYES
<22.50 Nil 
22.50 – 22.75 4 
22.76 – 23.00 20 
> 23.00 26 
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LENS THICKNESS – AXIAL LENGTH RATIO 
In this group of 50 eyes, the LT/AL ratio showed a mean value of 1.64 
± 0.09. 42 eyes showed the LT/AL ratio to be within 1.51 -1.75, 7 eyes were 
>1.75 and only one eye was <1.50. 
 
 NO: OF EYES
1.25 – 1.50 1 
1.51 – 1.75 42 
> 1.75 7 
 
PRIMARY ANGLE CLOSURE GLAUCOMA 
AGE AND SEX DISTRIBUTION 
Among the 25 PACG patients there were 12 males and 13 females. In 
the 41-50 yrs age group 15 patients were studied and the remaining 10 were in 
the 31-40 yrs age group 
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SEX DISTRIBUTION 
MALE  12 
FEMALE 13 
 
AGE DISTRIBUTION  
AGE IN YEARS NO: OF PATIENTS
31 – 40 10 
41 – 50 15 
 
CENTRAL CORNEAL THICKNESS 
THICKNESS IN MICRONS NO: OF EYES
< 501 3 
501 – 550 27 
551 – 600 16 
> 600 4 
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The total number of eyes studied were 50 out of which 27 eyes had a 
corneal thickness in the range of 501-550 microns.3 eyes had a CCT < 501 
microns and 4 eyes had a CCT>600 microns. The remaining 16 eyes were 
measured to have a CCT with in 551-600 microns. The average CCT was 
found to 544.72 microns ± 31.47. 
ANTERIOR CHAMBER DEPTH 
DEPTH IN MM NO: OF EYES
< 2.01 1 
2.01 – 2.25 35 
2.26 – 2.50 13 
> 2.50 1 
 
Of the 50 eyes studied, 35 eyes had an AC depth of 2.01-2.25 mm, 13 
eyes were with in 2.26 – 2.50 mm. Only one eye was <2.01 mm and one eye 
>2.50 mm. The mean ACD in mm in this group was 2.20 ± 0.13 
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LENS THICKNESS 
THICKNESS IN MM NO: OF EYES
4.26 – 4.50 10 
4.51 – 4.75 38 
> 4.76 2 
 
The lens thickness was more in this group of 38 eyes measuring 4.51-
4.75mm followed by 10 eyes in 4.26 – 4.50 mm. The remaining 2 eyes 
measured >4.76 mm. The average LT was 4.60mm ± 0.12. 
AXIAL LENGTH 
LENGTH IN MM NO: OF EYES
21.75 – 22.00 16 
22.01 – 22.25 27 
22.26 – 22.50 7 
 
The mean AC in this group was 22.07mm ± 0.18. 27 eyes of total 50 
eyes had axial length within 22.01 – 22.25 mm, 16 eye showed axial length of 
21.75-22.00 mm and 7 eyes  had axial length 22.26 – 22.50 mm. 
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LENS THICKNESS – AXIAL LENGTH RATIO 
 NO: OF EYES
< 2.00 6 
2.01 – 2.25 44 
 
44 eyes showed LT/AL ratio of 2.01-2.25 only 6 eyes showed <2.00. 
The average LT/AL ratio was 2.08 ± 0.06. 
GROUP - B 
MYOPES 
AGE AND SEX DISTRIBUTION 
Among the 25 myopic patients studied, 14 were males and 11 were 
females. 10 of them were within the 11 – 20 age groups and the remaining 15 
in 21 – 30 age groups.  
SEX DISTRIBUTION 
MALE 14 
FEMALE 11 
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AGE DISTRIBUTION 
AGE IN YEARS NO: OF EYES
11 – 20 10 
21 – 30 15 
 
CENTRAL CORNEAL THICKNESS 
THICKNESS IN MICRONS NO: OF EYES
< 501 Nil 
501 – 550 25 
551 – 600 23 
> 600 2 
 
The CCT was measured for 50 eyes of 25 patients. Half of them had a 
value in the range of 501 – 550 microns. Only 2 eyes had a corneal thickness 
of more than 600 microns.  
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ANTERIOR CHAMBER DEPTH 
Most of the eyes had an ACD ranging from 3.26 to 3.50 mm with only 
one being in the range of 3.76 and 4.00.  
DEPTH IN MM NO: OF EYES
3.00 – 3.25 5 
3.26 – 3.50 28 
3.51 – 3.75 16 
3.76 – 4.00 1 
 
LENS THICKNESS 
Maximum number of eyes had lens thickness within 3.26 to 3.75 mm. 
The average lens thickness was 3.5 mm.  
THICKNESS IN MM NO: OF EYES
3.00 – 3.25 0 
3.26 – 3.50 26 
3.51 – 3.75 22 
3.76 – 4.00 2 
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AXIAL LENGTH 
The average axial length of the myopic patients was found to be 23.72 
± 0.20 mm. The axial length of 22 eyes was within 23.51 to 23.75 mm. 14 
eyes had an axial length between 23.76 – 24.00 mm and 5 eyes measured 
greater than 24.00 mm. 
LENGTH IN MM NO: OF EYES
23.25 – 23.50 9 
23.51 – 23.75 22 
23.76 – 24.00 14 
>24.00 5 
 
LENS THICKNESS – AXIAL LENGTH RATIO 
The LT/AL ratio was within 1.25 – 1.50 in 35 eyes (70 %) and the rest 
was more than 1.51. The average LT/AL ratio in this group was 1.47 ± 0.06 
 NO: OF EYES
1.25 – 1.50 35 
1.51 – 1.75 15 
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HYPERMETROPES 
AGE AND SEX DISTRIBUTION 
Of the 25 hypermetropic patients studied, 11 were males and 14 were 
females. Only 8 of the total 25 patients were in 11-20 years age group and the 
rest 22 were within 21-30 years age group. 
SEX DISTRIBUTION 
MALE 11 
FEMALE 14 
 
AGE DISTRIBUTION  
AGE IN YEARS NO: OF EYES
11 – 20 8 
21 – 30 22 
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CENTRAL CORNEAL THICKNESS 
THICKNESS IN MICRONS NO: OF EYES
< 501 Nil 
501 – 550 30 
551 – 600 20 
> 600 Nil 
 
The average CCT of the hypermetropes was 545.08 ± 21.80 microns 
with all 50 eyes falling between 501-600 microns, 30 eyes ranged from 501-
550 microns and the rest 20 eyes from 551-600 microns. 
ANTERIOR CHAMBER DEPTH 
DEPTH IN MM NO: OF EYES 
< 2.50 Nil 
2.50 – 2.75 15 
2.76 – 3.00 33 
3.01 – 3.25 2 
 
The anterior chamber depth of this group of 50 eyes showed an 
average of 2.82 ± 0.11mm. The ACD was within 2.76-3.00 mm in 33 eyes 
followed by 15 eyes within 2.50-2.75 mm. 
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LENS THICKNESS 
THICKNESS IN MM NO: OF EYES
< 4 7 
4.01 – 4.25 15 
4.26 – 4.50 28 
 
This group showed an average LT of 4.22 ± 0.15 mm. The lens 
thickness was between 4.26 – 4.50 mm in 28 eyes, 4.01-4.25 mm in 15 eyes 
and <4.0 mm in 7 eyes. 
AXIAL LENGTH 
LENGTH IN MM NO: OF EYES
21.75 – 22.00 4 
22.01 – 22.25 23 
22.26 – 22.50 23 
> 22.50 Nil 
 
The average AL in this group was 22.22 ± 0.14 mm. 46 eyes had AL 
from 22.01 – 22.50 and only 4 eyes had axial length < 22.01. None of the eyes 
had axial length more than 22.50 mm. 
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LENS THICKNESS – AXIAL LENGTH RATIO 
 
 NO: OF EYES
1.51 – 1.75 1 
1.76 – 2.00 49 
 
 
Only one eye had LT / AL ratio < 1.76 and the rest 49 eyes showed 
LT/AL ratio between 1.76 and 2.00. The mean LT/AL ratio was 1.90 ± 0.07. 
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DISCUSSION 
The overall results of the both groups are tabulated below. The average 
measurements of the biometric parameters among the glaucoma patients 
showed that the PACG patients have a small anterior chamber, thicker lens 
and a shorter axial length than the POAG patients. A similar comparison 
among the refractive error group showed that the Hypermetropic patients have 
a small anterior chamber, thicker lens and a shorter axial length when 
compared to the myopic patients. 
GROUP A 
 
POAG PACG BIOMETRIC 
PARAMETERS MEAN S D MEAN S D 
C C T (µ) 548.36 24.71 544.72 31.47 
A C D (mm) 3.39 0.20 2.20 0.13 
L T (mm) 3.79 0.19 4.60 0.12 
A L  (mm) 23.12 0.35 22.07 0.18 
L T / A L 1.64 0.09 2.08 0.06 
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GROUP B 
MYOPES HYPERMETROPES BIOMETRIC 
PARAMETERS MEAN S D MEAN S D 
C C T (µ) 550.92 19.27 545.08 21.80 
A C D (mm) 3.44 0.16 2.82 0.11 
L T (mm) 3.50 0.14 4.22 0.15 
A L  (mm) 23.72 0.20 22.22 0.14 
L T / A L 1.47 0.06 1.90 0.07 
 
The student’s t test for independent samples was used to compare 
statistically and analyse the significance of association of the two groups. The 
results are as follows.  
MYOPES AND POAG 
The lens thickness, axial length and the Lens thickness / axial length 
factor (LAF) showed high statistical significance with a p value less than 
0.001 significant at 1% level. The anterior chamber depth and central corneal 
thickness among the two groups did not show statistical significance. 
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HYPERMETROPES AND PACG 
The two groups showed a high statistical significance at 1% level with 
p value less than 0.001 for the following biometric parameters namely lens 
thickness, anterior chamber depth, axial length and the lens thickness / axial 
length factor. There was no statistical association of central corneal thickness 
among the two groups.  
Angle closure glaucoma is commoner in India than in the west. The 
exact reason for this is not clearly understood. On comparing the axial length, 
the anterior chamber depth and lens thickness among the PACG and 
hypermetropes, it is found to be statistically significant. Marcowitz SN, Morin 
JD have shown the anatomical predisposition of patients with PACG in which 
they have studied ultrasonographic biometric measurements. Their analysis 
showed an apparently abnormal pattern of growth of the lens, its thickness 
increasing at an accelerated rate between 4th and 6th decades (16). A similar 
population based study of ocular biometry by George R, Paul PG et, al., have 
shown that south Indian eyes with angle closure glaucoma and occludable 
angles seemed to have significantly shorter axial lengths, shallower anterior 
chambers and greater lens thickness compared to the normal group (19).  
Sihota R, Gupta V et, al., have concluded in their study that the ocular 
parameters of asymptomatic or creeping angle closure eyes were significantly 
different from eyes having POAG. Open angle glaucoma and normal eyes 
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were comparable, but different from angle closure group in having a deep 
anterior chamber, thicker lens and longer axial length (11).  
Caprioli J, Spaeth G L et, al have shown that AC Depth is a function of 
sex age and refractive error (20).  
The LAF of the PACG in this study was 2.08 ± 0.06. a similar result of 
1.87 ± 0.11 in 30 – 39 age group and 2.08 ± 0.61 was found in the study of 
Markowitz et, al., (16) 
The lens thickness / axial length factor in patients with PACG proved 
to greater than normal (30 – 39 years age group 1.83 ± 0.3 / 40 – 49 years age 
group 1.9 ± 0.32) for that group. A similar result was seen in the 
hypermetropic patients in this study.  
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CONCLUSION 
• Primary angle closure glaucoma seems to be associated with shallower 
anterior chambers, thicker lenses and shorter axial length.  
 
• The basic biometric parameters namely the anterior chamber depth, 
lens thickness, the axial length and the lens thickness / axial length 
ratio of the hypermetropes show a strong and significant association 
when compared with the Primary angle closure glaucoma patients. 
 
• Lens thickness / axial length factor standardizes the assessment of the 
eyes with angle closure glaucoma. It is highly reliable and reproducible 
and easily chart the clinical course of the eye examined.  
 
• As ultrasonography is now a commonly done office procedure, 
measurements of axial length, lens thickness, and the anterior chamber 
depth could be done routinely as part of screening to predict the eyes 
that may go in for angle closure glaucoma.  
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PROFORMA 
  
  
NAME: OP / IP NO: 
  
AGE: GLAUCOMA CL. NO: 
  
SEX: MALE / FEMALE DATE: 
  
ADDRESS:  
  
OCCUPATION:  
  
GENERAL HISTORY:  
  
DIABETIC  
  
HYPERTENSIVE  
 
CARDIO VASCULAR / CEREBRO VASCULAR 
  
OTHER SYSTEMIC ILLNESS  
 
PRIOR NON-OCULAR SURGERY 
 
CURRENT SYSTEMIC MEDICATIONS / DRUG ALLERGIES 
  
FAMILY HISTORY OF GLAUCOMA  
  
PERSONAL HISTORY: SMOKER / ALCOHOLIC 
  
OCULAR HISTORY:  
  
PRESENTING SYMPTOMS: DEFECTIVE VISION / FIELD DEFECT / ROUTINE SCREENING 
 
AGE OF ONSET / DURATION OF COMPLAINTS: 
  
 RE LE 
DEFECTIVE VISION  
  
HEAD ACHE  
  
EYE PAIN  
  
REDNESS  
  
FIELD EFFECT  
  
COLOURED HALOES  
  
HISTORY OF FREQUENT CHANGE OF 
GLASSES: 
 
  
EPISODES OF BLURRED VISION:  
  
H/O OCULAR TRAUMA  
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H/O PREVIOUS EYE DISEASE OR 
SURGERY: 
 
  
H/O PROLONGED USE OF STEROIDS 
[TOPICAL / SYSTEMIC]: 
 
  
PREVIOUS TREATMENT:  
  
PRESENT TREATMENT:  
  
EXAMINATION:  
  
GENERAL EXAMINATION:  
  
GENERAL CONDITION:  
  
PULSE: BP: 
  
OCULAR EXAMINATION:  
 RE LE 
VISUAL ACUITY (BY SNELLEN’S):  
  
WITH PIN HOLE:  
  
REFRACTION:  
  
NEAR VISION:  
  
LIDS:  
  
CONJUNCTIVA:  
  
CORNEA:  
  
ANTERIOR CHAMBER:  
  
IRIS  
  
PUPIL  
  
LENS  
  
GONIOSCOPY  
SHAFFERS  
  
INTRA OCULAR TENSION  
APPLANATION:  
  
FUNDUS:  
  
DISTANT DIRECT  
  
DIRECT:  
DISC:  SIZE  
  
SHAPE  
  
MARGIN  
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COLOUR  
  
CUP: DISC RATIO  
  
VESSELS  
  
NEURO RETINAL RIM:  
  
LAMINAR DOT SIGN:  
  
NASAL SHIFT OF VESSELS:  
  
BAYONETTING:  
  
PRESENCE OF HAEMORRHAGES:  
  
  
NERVE FIBRE LAYER:  
NORMAL / WEDGE DEFECT / DIFFUSE / ATROPHY 
  
MACULA:  
  
OTHER FINDINGS:  
  
FIELD TESTING:  
  
MANUAL: BJERRUM’S KINETIC  
  
  
AUTOMATED PERIMETRY:  
  
  
BIOMETRIC PARAMETERS:  
  
CORNEAL THICKNESS:  
  
ANTERIOR CHAMBER DEPTH:  
  
LENS THICKNESS:  
  
AXIAL LENGTH:  
  
L A F  
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KEY TO MASTER CHART 
 
R Sph   -  Refraction sphere in diopters 
R Cyl   - Refraction cylinder in diopters 
V / A   - Visual acuity 
IOP   - Intra ocular pressure in mm of Hg 
CCT   - Central corneal thickness in µ. 
ACD    - Anterior chamber depth in mm 
LT    - Lens thickness in mm 
AL   - Axial Length in mm 
LT / AL  - Lens thickness – Axial length ratio 
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LIST OF SURGERIES   : 
 
 
S. 
No 
NAME AG/SX IP NO DIAGNOSIS D. O. S PROCEDURE 
1.  GOPAL 65/M 382619 RE – IMC 10.07.04 RE-ECCE/PCIOL 
2. PARVATHI 58/F 382759 BE–IMCL>R 17.07.04 RE-ECCE/PCIOL 
3. KAMSALA 50/F 382947 BE–IMCL>R 31.07.04 LE-ECCE/PCIOL 
4. SULOCHANA 60/F 390756 BE–IMCR>L 27.04.05 RE-ECCE/PCIOL 
5. BABU                 53/M 391787 BE-IMC R>L 10.05.05 RE-ECCE/PCIOL 
6. KRISHNAVENI 70/F 393782 RE – MC 12.07.05 RE-ECCE/PCIOL 
7. SAVITHRI 58/F 390999 BE–IMC R>L 18.08.05 RE-ECCE/PCIOL 
8. SUSAI 59/M 396179 LE – IMC 03.10.05 LE-ECCE/PCIOL 
9. ANANDAN 65/M 399979 RE – IMC 08.11.05 RE-ECCE/PCIOL 
10. NARAYANAN 70/M 392147 LE – IMC 25.01.06 LE – SICS/PCIOL 
11. VELUSAMY 52/M 392436 BE–IMC L>R 01.02.06 RE – SICS/PCIOL 
12. MUNIAMMAL 65/F 399423 BE-IMC L>R 15.02.06 LE – SICS/PCIOL 
13. RANI 52/F 399415 LE – MC 17.02.06 LE – SICS/PCIOL 
14. ASHRAFUNISA 68/F 399442 BE-IMC R>L 22.02.06 RE – SICS/PCIOL 
15. AYISHA BEE 55/F 399961 BE-IMC R>L 09.03.06 RE – SICS/PCIOL 
16. SUNDARAMMA 65/F 400200 RE – MC  16.03.06 RE – SICS/PCIOL 
17. SAMSHUDIN 58/M 400474 RE – IMC 23.03.06 RE – SICS/PCIOL 
18. INDRANI 52/F 400576 RE – IMC   30.03.06 RE – SICS/PCIOL 
19. MUNIAMMAL 60/F 394493 RE-FUNGAL 
CORNEAL ULCER 
WITH HYPOPYON 
22.06.05 RE-TKP 9MM OVER 
8MM 
20. RAVI 17/M 25789 LE CHALAZION 21.05.05 LE – I & C 
21. KAVERI 37/F 27240 RE-PTERYGIUM 21.05.05 EXCISION 
22.  RAJAMMAL 35/F 384392 LE-FUNGAL 
CORNEAL ULCER 
WITH HYPOPYON 
20.06.05 LE – AC WASH 
WITH AMP – B  
23.  MUNIAPPAN 59/M 83120 LE-PAN 
OPHTHALMITIS 
26.11.05 LE-EVISCERATIONQ 
24.  SHANTHI 52/F 376292 RE-ABSOLUTE 
GLAUCOMA 
08.12.05 RE-CYCLOCRYO 
25.  LAKSHMI 50/F 396830 RE-CHR. 
DACROCYSTITIS 
07.02.06 RE DCT 
26. BABU 09/M 396857 RE-TRAUMATIC 
ENDOPHTHALMITIS 
07.02.06 RE-INTRA VITREAL 
INJ. OF 
BR.SP.ANTBIOTICS 
27. MALAKONDIAH 55/M 387906 BE-SEC ACG  RECOMBINED SUR 
28. GIRIJA 45/F 402574 BE-PACG  RE-AG SURGERY 
29. SHANKAR 32/M 402574 RE-CHR. 
DACROCYSTITIS 
08.05.06 RE – DCR 
30. JAIBUNISA 15/F 397265 RE-OLD RHEG.RD 16.06.06 RE-RD SURG (360º 
ENCIRCLAGE WITH 
CRYO WITH SRF 
DRAINAGE) 
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POAG PACG MYOPE HYP
LT / A L  RATIO
S.NONAME AGE SEX OP/IP R Sph R cyl AXIS V/A IOP CCT ACD LT AL LT/AL
1 ANTHONY 21 M #### 1.75 0.5 90 6 by 6 13 526 2.71 3.99 22.22 1.80
2 ANTHONY 21 M #### 1.5 0.75 90 6 by 6 14 516 2.85 4.00 22.25 1.80
3 ARUMUGAM 27 M #### 2 6 by 6 15 569 2.80 4.05 22.10 1.83
4 ARUMUGAM 27 M #### 1.5 6 by 6 16 568 2.86 4.26 22.05 1.93
5 ARUNA 23 F #### 1.75 6 by 6 12 524 2.86 4.27 22.41 1.91
6 ARUNA 23 F #### 1.75 0.75 90 6 by 6 14 528 2.87 4.29 22.36 1.92
7 ELAVARASI 27 F #### 2 6 by 6 16 529 2.85 3.95 22.25 1.78
8 ELAVARASI 27 F #### 1.75 6 by 6 15 535 2.89 4.05 22.27 1.82
9 GRACY 25 F #### 2.25 6 by 6 15 548 2.80 4.40 22.31 1.97
10 GRACY 25 F #### 2.5 6 by 6 12 532 2.67 4.48 22.12 2.03
11 HARI 25 M #### 2.5 6 by 6 14 563 2.72 4.33 22.25 1.95
12 HARI 25 M #### 1.75 6 by 6 13 580 2.89 4.43 22.32 1.98
13 JEEVA 30 M #### 1.5 6 by 6 12 510 2.90 3.95 22.31 1.77
14 JEEVA 30 M #### 1.75 6 by 6 14 508 2.82 4.14 22.22 1.86
15 JYOTHI 18 F #### 2.75 6 by 6 15 548 2.61 4.38 22.27 1.97
16 JYOTHI 18 F #### 2.5 6 by 6 15 537 2.79 4.39 22.18 1.98
17 KAMALA 28 F #### 2.75 0.5 90 6 by 6 16 533 2.97 4.02 22.26 1.81
18 KAMALA 28 F #### 2.75 0.5 90 6 by 6 14 531 2.79 4.03 22.25 1.81
19 LATHA 22 F #### 2.5 6 by 6 15 555 2.71 4.19 21.88 1.91
20 LATHA 22 F #### 2.75 6 by 6 13 545 2.89 4.33 21.98 1.97
21 LAVANYA 14 F #### 2.75 6 by 6 12 515 2.80 4.10 22.07 1.86
22 LAVANYA 14 F #### 1.5 6 by 6 14 520 2.95 4.21 22.08 1.91
23 MOHANA 26 F #### 1.5 6 by 6 15 540 2.85 4.24 22.24 1.91
24 MOHANA 26 F #### 2.5 6 by 6 13 550 2.92 4.43 22.33 1.98
25 MUNIAMMA 26 F #### 2.5 6 by 6 14 552 2.85 4.29 22.31 1.92
26 MUNIAMMA 26 F #### 2 6 by 6 14 533 2.92 4.35 22.06 1.97
27 PARIMALA 23 F #### 1.75 6 by 6 16 554 2.96 4.26 22.35 1.91
28 PARIMALA 23 F #### 1.5 6 by 6 14 564 2.85 4.30 22.46 1.91
29 PRAKASH 24 M #### 1.5 6 by 6 15 527 2.70 4.28 22.30 1.92
30 PRAKASH 24 M #### 1.25 6 by 6 13 528 2.54 4.36 22.29 1.96
31 PREMA 26 F #### 1.5 6 by 6 12 581 2.70 4.25 22.24 1.91
32 PREMA 26 F #### 1.5 6 by 6 15 582 2.76 4.46 22.33 2.00
33 PUNNIYAKODI 25 M #### 2.75 6 by 6 13 548 2.77 3.92 22.26 1.76
34 PUNNIYAKODI 25 M #### 2.75 6 by 6 14 547 2.88 4.08 22.01 1.85
35 RAJALINGAM 29 M #### 1.75 6 by 6 12 513 2.78 3.96 22.08 1.79
36 RAJALINGAM 29 M #### 1.5 6 by 6 15 504 2.85 4.09 22.26 1.84
37 RATHI 14 F #### 1.5 1 180 6 by 6 15 553 2.72 4.21 21.91 1.92
38 RATHI 14 F #### 1.5 1 180 6 by 6 13 557 2.72 4.26 21.99 1.94
39 SELVAM 21 M #### 1 6 by 6 13 550 2.83 4.26 22.24 1.92
40 SELVAM 21 M #### 1.25 6 by 6 15 535 2.84 4.36 22.07 1.98
41 SHANKAR 17 M #### 1.5 6 by 6 16 567 2.74 3.97 22.39 1.77
42 SHANKAR 17 M #### 1.25 6 by 6 14 560 2.88 4.14 22.46 1.84
43 SIVANANDAM 22 M #### 2.25 6 by 6 14 566 3.16 4.20 22.07 1.90
44 SIVANANDAM 22 M #### 2.5 6 by 6 15 552 3.14 4.28 22.17 1.93
45 SUBAIDA 29 F #### 2.5 6 by 6 13 530 2.62 4.29 22.18 1.93
46 SUBAIDA 29 F #### 2 6 by 6 14 525 2.82 4.34 22.29 1.95
47 THARANGINI 26 F #### 2.5 1 70 6 by 6 13 576 2.82 4.28 22.25 1.92
48 THARANGINI 26 F #### 2.5 1.5 110 6 by 6 15 582 2.72 4.33 22.37 1.94
49 VIVEK 27 M #### 2.25 6 by 6 14 574 2.73 4.35 22.39 1.94
50 VIVEK 27 M #### 2 6 by 6 13 584 2.74 4.36 22.31 1.95
HYPERMETROPES
S.NO NAME (POAG) AGESEX OP/IP    VA IOP CCT ACD LT AL LT/AL
1 AMSA 43 F 35013 6 by 6 14 540 3.19 3.92 22.92 1.71
2 AMSA 43 F 35013 6 by 12p 15 542 3.07 4.03 22.84 1.76
3 BARATHIRAJA 47 M 35134 6 by 9 16 542 3.30 3.51 22.67 1.55
4 BARATHIRAJA 47 M 35134 6 by12 15 546 3.30 3.81 22.73 1.68
5 CHELLAPAN 37 M 40789 6 by 12 13 540 3.30 4.10 22.86 1.79
6 CHELLAPAN 37 M 40789 6 by 9 16 536 3.16 4.10 22.84 1.80
7 ELUMALAI 48 M 33345 6 by 6 16 504 3.48 3.50 22.77 1.54
8 ELUMALAI 48 M 33345 6 by 6 p 15 508 3.40 3.60 22.90 1.57
9 JAYANTHI 38 F 45678 6 by 6 14 569 3.45 3.63 23.14 1.57
10 JAYANTHI 38 F 45678 6 by12 16 563 3.40 3.75 23.11 1.62
11 JOHN 42 M 46342 6 by 9p 16 543 3.35 3.63 23.43 1.55
12 JOHN 42 M 46342 6 by 12 14 549 3.37 3.80 23.48 1.62
13 KOKILA 49 F 47812 6 by 6 15 524 3.72 3.61 23.85 1.51
14 KOKILA 49 F 47812 6 by12 15 526 3.72 3.61 23.85 1.51
15 MARGABANDU 45 M 34215 6 by 6p 17 536 3.30 3.72 22.86 1.63
16 MARGABANDU 45 M 34215 6 by 9 15 538 3.29 3.80 22.84 1.66
17 MARIAMMAL 45 F 39876 6 by12 14 520 3.40 3.85 22.68 1.70
18 MARIAMMAL 45 F 39876 6 by 6 14 540 3.18 3.90 22.81 1.71
19 PONNI 50 F 30000 6 by 12 17 607 3.17 3.92 23.46 1.67
20 PONNI 50 F 30000 6 by6 15 604 3.20 4.00 23.44 1.71
21 RAJATHI 42 F 31234 6 by 9 16 589 3.48 3.57 23.59 1.51
22 RAJATHI 42 F 31234 6 by 9 18 589 3.52 3.61 23.43 1.54
23 RAJENDRAN 36 M 36420 6 by 6 15 554 3.50 3.51 23.36 1.50
24 RAJENDRAN 36 M 36420 6 by 12 16 554 3.46 3.69 23.37 1.58
25 RAMANAN 44 M 41029 6 by 9 15 535 3.18 3.77 22.80 1.65
26 RAMANAN 44 M 41029 6 by 9 13 541 3.28 3.83 22.82 1.68
27 RAMZAN 31 F 48721 6 by 6p 14 547 3.35 4.05 22.95 1.76
28 RAMZAN 31 F 48721 6 by 12 15 537 3.25 4.05 22.85 1.77
29 RANI 42 F 45362 6 by6 14 507 3.49 4.00 23.57 1.70
30 RANI 42 F 45362 6 by 6 12 538 3.41 4.00 23.49 1.70
31 RANJITH 38 M 34444 6 by 9p 15 542 3.38 3.65 22.81 1.60
32 RANJITH 38 M 34444 6 by 12 13 540 3.37 3.80 22.87 1.66
33 RAVICHANDRAN 50 M 37676 6 by 6 15 600 3.08 3.64 23.39 1.56
34 RAVICHANDRAN 50 M 37676 6 by 12 15 598 3.10 3.80 23.63 1.61
35 SALEEM 49 M 32509 6 by 9 17 518 3.45 3.97 23.01 1.73
36 SALEEM 49 M 32509 6 by 6 14 546 3.50 4.02 23.09 1.74
37 SIDDIK 47 M 35987 6 by 6p 15 562 3.47 3.54 22.78 1.55
38 SIDDIK 47 M 35987 6 by 9 16 552 3.31 3.54 22.65 1.56
39 SUBHASINI 38 F 37874 6 by 12 14 590 3.66 3.85 23.22 1.66
40 SUBHASINI 38 F 37874 6 by12 16 593 3.52 3.87 23.28 1.66
41 SURESH 37 M 35656 6 by 6 18 545 3.92 3.54 23.35 1.52
42 SURESH 37 M 35656 6 by 12p 15 550 3.80 3.64 23.18 1.57
43 VADIVELU 40 M 40003 6 by 9 12 548 3.70 3.53 23.85 1.48
44 VADIVELU 40 M 40003 6 by 6 14 534 3.80 3.58 23.75 1.51
45 VALAIYAPATHI 49 M 32121 6 by 6 15 537 3.07 3.97 22.78 1.74
46 VALAIYAPATHI 49 M 32121 6 by 9 16 538 3.11 4.03 22.93 1.76
47 VASANTHI 33 F 30278 6 by 12 17 547 3.53 4.00 22.86 1.75
48 VASANTHI 33 F 30278 6 by 6 15 536 3.46 4.00 22.78 1.76
49 VENUGOPAL 34 M 45454 6 by 9 16 537 3.40 3.75 23.02 1.63
50 VENUGOPAL 34 M 45454 6 by 9 17 537 3.38 3.77 23.06 1.63
POAG
S.NONAME AGE SEX OP/IP    VA IOP CCT ACD LT AL LT/AL
1 DHANALAKSHMI 49 F 36758 6 by 12 14 567 2.26 4.48 21.75 2.06
2 DHANALAKSHMI 49 F 36758 6 by 6 16 570 2.19 4.80 21.81 2.20
3 HAMSARANI 50 F 45325 6 by 9 p 15 536 2.16 4.63 22.30 2.08
4 HAMSARANI 50 F 45325 6 by 12 16 544 2.14 4.63 22.15 2.09
5 LAKSHMI 41 F 34254 6 by 6 14 562 2.07 4.65 21.77 2.14
6 LAKSHMI 41 F 35254 6 by6 11 560 2.17 4.66 21.81 2.14
7 MANIVEL 38 M 44335 6 by12p 14 526 2.09 4.47 21.85 2.05
8 MANIVEL 38 M 44335 6 by 9 p 13 525 2.08 4.69 21.82 2.15
9 MATHI 32 M 41129 6 by12p 15 569 2.10 4.67 22.19 2.10
10 MATHI 32 M 41129 6 by 6 16 568 2.30 4.69 22.10 2.12
11 MD BIBI 50 F 34544 6 by 12 13 507 2.05 4.58 21.79 2.10
12 MD BIBI 50 F 34544 6 by 6 15 511 2.15 4.61 22.04 2.09
13 MEERA 39 F 43697 6 by 12 16 558 2.09 4.52 21.81 2.07
14 MEERA 39 F 43697 6 by 12 16 564 2.05 4.71 21.79 2.16
15 MOHAN 50 M 37765 6 by 9 p 17 495 2.50 4.57 22.26 2.05
16 MOHAN 50 M 37765 6 by 12 18 520 2.60 4.69 22.20 2.11
17 MURALI 35 M 37658 6 by 6 14 537 2.20 4.53 22.31 2.03
18 MURALI 35 M 37658 6 by 9 15 543 2.20 4.54 22.18 2.05
19 MUTHU 46 M 32986 6 by 12 15 512 2.19 4.39 22.30 1.97
20 MUTHU 46 M 32986 6 by 9 16 515 2.22 4.49 22.28 2.02
21 PRIYA 31 F 34576 6 by 6 17 565 2.00 4.52 22.06 2.05
22 PRIYA 31 F 34576 6 by 9p 15 561 2.02 4.59 22.17 2.07
23 PUGAZHENDI 42 M 45676 6 by12 13 602 2.43 4.64 22.25 2.09
24 PUGAZHENDI 42 M 45676 6 by 12 12 603 2.38 4.69 22.15 2.12
25 RAJAN 48 M 45345 6 by 6 11 580 2.26 4.64 21.86 2.12
26 RAJAN 48 M 45345 6 by 6p 14 579 2.29 4.84 22.08 2.19
27 RAJESWARI 40 F 36756 6 by 9p 18 536 2.24 4.61 22.17 2.08
28 RAJESWARI 40 F 36756 6 by 6 16 529 2.16 4.66 22.20 2.10
29 RAMZAN BEE 34 F 30987 6 by 6 15 526 2.22 4.63 22.10 2.10
30 RAMZAN BEE 34 F 30987 6 by 9 15 525 2.25 4.64 22.10 2.10
31 ROJA 38 F 43509 6 by12 12 510 2.26 4.37 22.19 1.97
32 ROJA 38 F 43509 6 by 12 14 508 2.19 4.67 21.72 2.15
33 SARASWATHI 47 F 45562 6 by 12 13 500 2.25 4.61 22.17 2.08
34 SARASWATHI 47 F 45562 6 by 9 15 497 2.35 4.63 22.20 2.09
35 SATHYAMOORTHI 45 M 37685 6 by 6 15 580 2.28 4.52 22.12 2.04
36 SATHYAMOORTHI 45 M 37685 6 by 6p 12 596 2.04 4.54 22.26 2.04
37 SHANKAR 34 M 43523 6 by 12p 16 623 2.22 4.66 22.15 2.10
38 SHANKAR 34 M 43523 6 by 6 17 612 2.43 4.73 22.01 2.15
39 SHANTHI 48 F 34276 6 by12 15 533 1.98 4.47 22.09 2.02
40 SHANTHI 48 F 34276 6 by 9 18 539 2.15 4.62 21.80 2.12
41 SOMU 42 M 36758 6 by 12p 17 559 2.03 4.62 22.21 2.08
42 SOMU 42 M 36758 6 by 9 15 563 2.16 4.73 22.00 2.15
43 SRINIVASAN 42 M 35625 6 by 6 17 520 2.20 4.65 21.95 2.12
44 SRINIVASAN 42 M 35625 6 by 6 16 512 2.29 4.75 21.84 2.17
45 SUNDARAMOORTH 45 M 34524 6 by 12 17 513 2.34 4.35 22.23 1.96
46 SUNDARAMOORTH 45 M 34524 6 by 6 15 514 2.17 4.40 22.22 1.98
47 VIDYA 32 F 34519 6 by 12 12 545 2.13 4.65 22.11 2.10
48 VIDYA 32 F 34519 6 by 9 13 540 2.01 4.69 22.30 2.10
49 VIMALA 48 F 36924 6 by 9p 14 544 2.18 4.25 22.00 1.93
50 VIMALA 48 F 36924 6 by 6 13 533 2.13 4.42 22.17 1.99
PACG
S.NO NAME AGE SEX OP/IP R SphR cylAXIS V/A IOP CCT ACD LT AL LT/AL
1 AMIT RAJ 19 M 38493 -3 6 by 6 12 546 3.40 3.51 23.93 1.47
2 AMIT RAJ 19 M 38493 -3.5 6 by 6 10 534 3.38 3.54 24.05 1.47
3 BADRI 16 M 36985 -3.5 6 by 6 13 546 3.45 3.34 24.01 1.39
4 BADRI 16 M 36985 -4 6 by 6 11 525 3.38 3.59 24.09 1.49
5 BALAMURUGAN 15 M 38518 -1.75 -0.8 180 6 by 6 13 541 3.68 3.27 23.55 1.39
6 BALAMURUGAN 15 M 38518 -1.75 -0.8 180 6 by 6 14 552 3.58 3.48 23.42 1.49
7 BEER MD 16 M 36830 -2 6 by 6 15 562 3.62 3.33 23.97 1.39
8 BEER MD 16 M 36830 -3.75 6 by 6 13 572 3.77 3.47 23.96 1.45
9 DIVYA 15 F 51175 -3.5 6 by 6 16 534 3.59 3.49 23.76 1.47
10 DIVYA 15 F 51175 -2.5 6 by 6 18 530 3.33 3.60 23.64 1.52
11 GANGADEVI 16 F 37182 -2.5 6 by 6 11 605 3.34 3.81 23.96 1.59
12 GANGADEVI 16 F 37182 -1.25 6 by 6 14 573 3.28 3.96 23.93 1.65
13 JANANI 15 F 37226 -1.5 6 by 6 12 582 3.55 3.47 23.51 1.48
14 JANANI 15 F 37226 -3.5 6 by 6 11 574 3.43 3.49 23.46 1.49
15 JOTHI 29 F 33251 -2.75 -0.5 180 6 by 6 17 532 3.37 3.60 23.51 1.53
16 JOTHI 29 F 33251 -3.75 -0.5 180 6 by 6 15 522 3.17 3.66 23.40 1.56
17 LOGESWARI 22 F 31525 -3.5 6 by 6 14 561 3.29 3.44 23.65 1.45
18 LOGESWARI 22 F 31525 -2.25 6 by 6 15 542 3.46 3.52 23.71 1.48
19 NASREEN MD 16 F 41269 -2.5 6 by 6 15 536 3.36 3.39 23.96 1.41
20 NASREEN MD 16 F 41269 -2.75 6 by 6 16 550 3.46 3.52 23.96 1.47
21 PADMALAKSHMI 20 F 41797 -2.75 -0.8 180 6 by 6 14 543 3.26 3.44 23.95 1.44
22 PADMALAKSHMI 20 F 41797 -1.75 -0.5 180 6 by 6 17 550 3.28 3.44 23.90 1.44
23 PARTHASARATHY 17 M 36973 -1.75 6 by 6 16 546 3.63 3.28 23.95 1.37
24 PARTHASARATHY 17 M 36973 -2.5 6 by 6 14 555 3.43 3.55 23.90 1.49
25 PRADEEP 16 M 36900 -3.25 6 by 6 16 554 3.65 3.35 24.05 1.39
26 PRADEEP 16 M 36900 -4.75 6 by 6 14 521 3.61 3.44 24.11 1.43
27 RAJENDRAN 16 M 37333 -0.75 -0.5 180 6 by 6 12 554 3.69 3.26 23.67 1.38
28 RAJENDRAN 16 M 37333 -1.75 6 by 6 14 554 3.52 3.31 23.66 1.40
29 RATHISH 17 M 42487 -1.75 6 by 6 12 530 3.36 3.43 23.61 1.45
30 RATHISH 17 M 42487 -1.25 6 by 6 12 524 3.43 3.58 23.60 1.52
31 ROHINI 15 F 41470 -1.75 -0.5 160 6 by 6 17 564 3.43 3.60 23.57 1.53
32 ROHINI 15 F 41470 -1.5 -0.5 20 6 by 6 16 554 3.41 3.70 23.45 1.58
33 SAMUEL 15 M 38100 -3 6 by 6 13 590 3.65 3.28 23.87 1.37
34 SAMUEL 15 M 38100 -1.75 6 by 6 14 602 3.68 3.34 23.93 1.40
35 SELVAM 28 M 36932 -1.5 -0.8 110 6 by 6 17 555 3.19 3.52 23.57 1.49
36 SELVAM 28 M 36932 -1.5 -0.5 70 6 by 6 15 552 3.12 3.52 23.49 1.50
37 SELVI 22 M 39507 -1.5 6 by 6 14 524 3.13 3.60 23.55 1.53
38 SELVI 22 M 39507 -2.75 6 by 6 12 526 3.23 3.64 23.58 1.54
39 SENTHIL 24 M 36820 -2.75 6 by 6 12 545 3.49 3.51 23.66 1.48
40 SENTHIL 24 M 36820 -1.75 6 by 6 12 531 3.52 3.65 23.61 1.55
41 SIDDIQUE 17 M 44865 -1.5 6 by 6 16 552 3.31 3.54 23.50 1.51
42 SIDDIQUE 17 M 44865 -2.5 6 by 6 15 568 3.31 3.54 23.50 1.51
43 SUDHA 14 F 39139 -2.25 -1 180 6 by 6 12 557 3.41 3.39 23.61 1.44
44 SUDHA 14 F 39139 -2.5 -1 180 6 by 6 16 546 3.29 3.59 23.72 1.51
45 SUGANYA 16 F 35158 -2.25 6 by 6 14 546 3.68 3.48 23.67 1.47
46 SUGANYA 16 F 35158 -1.5 -0.8 90 6 by 6 13 542 3.68 3.58 23.62 1.52
47 VIJAY 25 M 40873 -3.5 6 by 6 16 562 3.50 3.44 23.62 1.46
48 VIJAY 25 M 40873 -2.75 6 by 6 18 570 3.52 3.49 23.64 1.48
49 VIJAYAKUMARI 22 F 37312 -2.25 6 by 6 16 554 3.50 3.43 23.50 1.46
50 VIJAYAKUMARI 22 F 37312 -2 -0.5 90 6 by 6 17 556 3.30 3.46 23.50 1.47
MYOPES
